United Guardian (UG) Asset Writedowns and Impairment (2011 - 2026)
United Guardian's (UG) quarterly Asset Writedowns and Impairment came in at -$3000.0 in Q2 2026, down 185.37% year-over-year from $3514.0 in Q2 2025, and up 40.0% quarter-over-quarter from -$5000.0 in Q1 2026.
Powered by 
Analysis
United Guardian (UG) Asset Writedowns and Impairment (2011 - 2026) Analysis & Trends
United Guardian has disclosed Asset Writedowns and Impairment across 9 years of filings, most recently posting -$3000.0 for Q2 2026.
- In Q2 2026, Asset Writedowns and Impairment fell 185.37% year-over-year to -$3000.0; the TTM figure through Jun 2026 stood at -$12459.0 (down 182.63% YoY), while the FY2025 annual figure was $2827.0, up 119.9% from the prior year.
- Asset Writedowns and Impairment came in at -$3000.0 for Q2 2026 at United Guardian, up from -$5000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $30851.0 in Q4 2022 to a low of -$54000.0 in Q4 2023.
- Average Asset Writedowns and Impairment over 5 years is -$434.18, with a median of $1343.0 recorded in 2022.
- The largest YoY upside for Asset Writedowns and Impairment was 537.98% in 2022 against a maximum downside of 377.62% in 2022.
- Over 5 years, Asset Writedowns and Impairment stood at $30851.0 in 2022, then sank by 275.03% to -$54000.0 in 2023, then surged by 114.43% to $7792.0 in 2024, then decreased by 27.96% to $5613.0 in 2025, then slumped by 153.45% to -$3000.0 in 2026.
- Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were -$3000.0 in Q2 2026, -$5000.0 in Q1 2026, and $5613.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.97 Bn | 622.21 Bn | 17.26 Bn |
| 2 | AbbVie | 441.24 Bn | 434.67 Bn | 12.70 Bn |
| 3 | Merck | 364.65 Bn | 357.51 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.30 Bn | 258.61 Bn | 11.24 Bn |
| 5 | Pfizer | 158.95 Bn | 147.25 Bn | 10.94 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.29 Bn | 44.29 Bn | - |
| 8 | Incyte | 25.27 Bn | 20.73 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.44 Bn | 18.78 Bn | 683.80 Mn |
| 10 | United Guardian | 32.67 Mn | 23.07 Mn | 1.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,000.00 |
| Mar 31, 2026 | -5,000.00 |
| Dec 31, 2025 | 5,613.00 |
| Sep 30, 2025 | -10,072.00 |
| Jun 30, 2025 | 3,514.00 |
| Mar 31, 2025 | 3,772.00 |
| Dec 31, 2024 | 7,792.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -17,000.00 |
| Dec 31, 2023 | -54,000.00 |
| Sep 30, 2023 | 22,240.00 |
| Jun 30, 2023 | -1,740.00 |
| Mar 31, 2023 | 16,500.00 |
| Dec 31, 2022 | 30,851.00 |
| Sep 30, 2022 | -9,997.00 |
| Jun 30, 2022 | 1,343.00 |
| Mar 31, 2022 | 6,803.00 |
| Dec 31, 2021 | -7,044.00 |
| Sep 30, 2021 | 3,601.00 |
| Jun 30, 2021 | 4,403.00 |